Proteomics

Dataset Information

0

Quantitative proteomics analysis based on data-independent acquisition reveals the effect of Shenling Baizhu powder (SLP) on protein expression in MAFLD rat liver tissue


ABSTRACT: Metabolic fatty liver disease (MAFLD) has become the most common chronic liver disease worldwide, with steatosis as the underlying pathology. At the same time, MAFLD is also a high-risk factor for the development of metabolic diseases. Shenling Baizhu powder (SLP) is a traditional Chinese herbal formula with good clinical efficacy in the treatment of MAFLD. However, its molecular mechanism for the treatment of MAFLD is still not fully understood. This study used quantitative proteomics analysis to reveal the mechanism of action of SLP in the treatment of MAFLD by discovering the effect of SLP on protein expression in the liver tissue of MAFLD rats. Orbitrap high-resolution liquid chromatography mass spectrometry (Q-Orbitrap LC-MS/MS) was used to identify the blood-entering compounds of SLP. The 18 SD male rats were randomly divided into 3 groups (n=6): Control group, HFD group and SLP group. The HFD group and SLP group were established as MAFLD rat models by feeding them with a high-fat diet for 4 weeks. Then, the SLP group was treated with SLP (10.89g / kg / d) for 3 weeks. Measurement of biochemical parameters and pathological status of the liver in each group of rats. Rat liver tissue was analyzed using DIA-based quantitative proteomics and validated by western blotting.

ORGANISM(S): Rattus Norvegicus

SUBMITTER: Tao Liu  

PROVIDER: PXD042049 | iProX | Sun May 07 00:00:00 BST 2023

REPOSITORIES: iProX

altmetric image

Publications

Quantitative proteomics analysis based on data-independent acquisition reveals the effect of Shenling Baizhu powder (SLP) on protein expression in MAFLD rat liver tissue.

Song Sufei S   Zheng Jixian J   Zhao Dongmei D   Zheng Anni A   Zhu Ye Y   Xu Qiuling Q   Liu Tao T  

Clinical proteomics 20231201 1


<h4>Background</h4>Metabolic associated fatty liver disease (MAFLD) has become the most common chronic liver disease worldwide, and it is also a high-risk factor for the development of other metabolic diseases. Shenling Baizhu powder (SLP) is a traditional Chinese herbal formula with good clinical efficacy against MAFLD. However, its molecular mechanism for the treatment of MAFLD is still not fully understood. This study used quantitative proteomics analysis to reveal the SLP action mechanism in  ...[more]

Similar Datasets

2016-07-01 | E-GEOD-48794 | biostudies-arrayexpress
2023-01-09 | GSE222093 | GEO
2021-12-02 | GSE189855 | GEO
2021-02-19 | E-MTAB-8928 | biostudies-arrayexpress
2018-01-01 | GSE102964 | GEO
2016-02-01 | E-GEOD-66316 | biostudies-arrayexpress
2021-08-24 | MTBLS3194 | MetaboLights
2018-12-31 | GSE107066 | GEO
2024-06-17 | GSE246221 | GEO
2016-02-01 | GSE66316 | GEO